fbpx Important case study of bad communication in flu prevention | Science in the net

Important case study of bad communication in flu prevention

Primary tabs

Read time: 3 mins

On Oct 17th, 2012, on the verge of the 2012 seasonal flu vaccine campaign, the Italian Ministry of Health suddenly announced the recall of 2.3 million doses of the Inflexal V flu vaccine, produced by the Dutch company Crucell. "Potential danger" to health was claimed for the recall. This news rapidly spread with alarm.
The Ministry of Health reassured the population that security problem should not be expected because no dose was put into circulation.
Nonetheless, an instant Poll commissioned by TELL ME Project to ISPO (see below) confirmed the rising distrust of Italian people toward vaccine: 20% of the Poll sample expressed growing opposition against the flu vaccine after the announced recall. But the story does not end here.

A few days later, on Oct 24th, the Italian Ministry of Health suspended the use and sale of four other influenza vaccines, produced by the pharmaceutical company Novartis. In a statement circulated with urgency, Italian citizens were asked not to buy or use these vaccines until further notice.
The Italian Medicines Agency (AIFA), the national authority responsible for the regulation of drugs in Italy, explained that the documentation submitted by the pharmaceutical company needs to include more safety checks and more details on the safety and quality of their vaccines. Such a precautionary measure is due to the reported appearance in the vaccines of protein aggregates that could decrease their effectiveness and possibly increase the likelihood of local reactions or influenza-like symptoms, which commonly occur after administration of the seasonal influenza vaccine. Following the Italian decision, four other European Union countries – Austria, France, Germany and Spain – plus Switzerland and Canada - have temporarily suspended the use of the accused vaccines.

On Oct 31st, this suspension has been lifted in Canada and Switzerland, following further risk assessments. Both Canadian and Swiss national regulatory authorities conducted their own laboratory tests and reviewed data submitted by Novartis before taking their decisions. Less straightforward the position assumed by Italy; at the same time of Canadian and Swiss official announcements, AIFA expressed the “likelihood of taking a warily positive attitude toward the possible removal, limited to some batches, of the prohibition of use of the Novartis vaccines”. Nine days later, on Nov 9th, AIFA proclaimed that the suspension of flu vaccines had been lifted, following the accurate review of the documentation provided by Novartis and further analysis carried out by both AIFA and the Institute for Superior Public Health (ISS).

The TELL ME Project has identified in this series of events an extremely interesting case study through which to investigate the mutual interplay between medical evidence, institutional information, public health campaign, public opinion and the possible consequences of a decrease in the efficiency of such a complex, interrelated mechanism. TELL ME has then commissioned an instant poll about the impact of these facts and communication on people’s attitude towards flu vaccination. Results are presented in the following slides.

Italian Poll on Flu Vaccine Recalled

Premio giovani ricercatrici e ricercatori


Il Gruppo 2003 per la ricerca scientifica indice la quarta edizione del "Premio giovani ricercatrici e ricercatori edizione 2025" per promuovere l'attività di ricerca e richiamare l'attenzione delle istituzioni e dell'opinione pubblica sulle nuove generazioni di scienziate e scienziati.



prossimo articolo

University Admissions and Talent in China: What Can Italy Learn?

Every year, millions of Chinese students take the Gaokao, an extremely tough exam that can change the course of a life. But what can this system teach us? Between intense pressure and paths to excellence, it offers a chance to reflect on the idea of merit in Italy as well.

Each year, over 12 million Chinese students sit for the Gaokao (高考), one of the most difficult and decisive university entrance exams in the world. This three-day test includes Chinese, Mathematics, English, and one elective subject from either the sciences or humanities. The maximum score varies by province, typically between 750 and 900, with the admission threshold for top universities exceeding 680–700 points. On average, fewer than 2% of students manage to get into elite institutions such as Peking University or Tsinghua University.